A subset of MMR‐proficient colon cancers responds to neoadjuvant immunotherapy
Tan et al. reveal that a distinct subset of early‐stage pMMR colon cancers can respond to neoadjuvant immunotherapy. In the NICHE‐2 trial, responders (26%) were characterized by chromosomal instability, TP53 mutations, and proliferative cell‐cycle programs, whereas nonresponders showed metabolic and stromal reprogramming with TGF‐β‐driven ...
Eleonora Piumatti +3 more
wiley +1 more source
BMI and PNI as predictors of treatment completion and survival in locally advanced HNSCC receiving sequential chemoradiotherapy. [PDF]
Zeynelgil E +6 more
europepmc +1 more source
α1ACT Is Essential for Survival and Early Cerebellar Programming in a Critical Neonatal Window [PDF]
Xiaofei Du +10 more
openalex +1 more source
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg +43 more
wiley +1 more source
Introducing the Seaweed Specialist Group of the IUCN Species Survival Commission
Nur Arafeh-Dalmau +15 more
doaj +1 more source
Monoblock or modular? Impact of stem design and conicity angle on long-term implant survival in revision total hip arthroplasty: a 20-year follow-up registry study on 3647 implants. [PDF]
Brunello M +6 more
europepmc +1 more source
Methods for the analysis of quality-of-life and survival data in health technology assessment.
Billingham, Abrams, Jones
openalex +2 more sources
Resveratrol improves health and survival of mice on a high-calorie diet
J. Baur +26 more
semanticscholar +1 more source
Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li +10 more
wiley +1 more source

